-
Mashup Score: 12Report calls for regulations around dangerous pathogen research - 2 month(s) ago
Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics at Harvard Chan School, discusses key takeaways from a new report that makes recommendations on…
Source: www.hsph.harvard.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 11Report calls for regulations around dangerous pathogen research - 2 month(s) ago
Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics at Harvard Chan School, discusses key takeaways from a new report that makes recommendations on…
Source: www.hsph.harvard.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 10Health Scientist (Data Scientist) - 2 month(s) ago
As a global leader in public health & health promotion, CDC is the agency Americans trust with their lives. In addition to our everyday work, each CDC employee has a role in supporting public health emergency management, whether through temporary assignments to emergency responses or sustaining other CDC programs and activities while colleagues respond. Join our team to use your talent, training, & passion to help CDC continue as the world’s premier public health organization. Visit www.cdc.gov
Source: www.usajobs.govCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 6Coronavirus Disease 2019 (COVID-19) - 3 month(s) ago
CDC provides credible COVID-19 health information to the U.S.
Source: www.cdc.govCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 15Regulating Risky Research: The Science and Governance of Pathogens of Pandemic Potential - 3 month(s) ago
The COVID-19 pandemic has renewed public interest in gain-of-function (GOF) research of concern on pathogens of pandemic potential. Are laboratory experiments to make pathogens more transmissible or virulent necessary for scientific progress? Do such experiments pose unacceptable risk? As Congress and the executive branch consider regulatory reforms, we sorely need constructive, evidence-based discussions of the […]
Source: www.aei.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 5Charting a course for better pneumococcal vaccines - 3 month(s) ago
A new platform for developing bacterial vaccines—the multiple antigen presenting system—could enable an affordable alternative to current pneumococcal conjugate vaccines. Here, the multiple antigen presenting system co-inventor Rick Malley, Senior Physician in Pediatrics, Boston Children’s Hospital, and Professor of Pediatrics, Harvard Medical School, speaks with Charlotte Barker, Editor, Vaccine Insights, about the fast-evolving pneumococcal vaccine field.
Source: www.insights.bioCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 2Defining and emulating target trials of the effects of postexposure vaccination using observational data - 4 month(s) ago
Postexposure vaccination has the potential to prevent or modify the course of clinical disease among those exposed to a pathogen. However, due to logistical constraints, postexposure vaccine trials have been difficult to implement in practice. In place of trials, investigators have used observational data to estimate the effectiveness or optimal timing window for postexposure vaccines, but the relationship between these analyses and those that would be conducted in a trial is often unclear. Here, we define several possible target trials for postexposure vaccination and show how, under certain conditions, they can be emulated using observational data. We emphasize the importance of the incubation period and the timing of vaccination in trial design and emulation. As an example, we specify a protocol for postexposure vaccination against mpox and provide a step-by-step description of how to emulate it using data from a healthcare database or contact tracing program. We further illustrate
Source: www.medrxiv.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 18JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data - 4 month(s) ago
JYNNEOSTM vaccine has been used as post-exposure prophylaxis (PEP) during a mpox outbreak in New York City (NYC). Data on effectiveness are limited.Ef…
Source: www.sciencedirect.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 4Reimagining our Shared Approach to Fall Respiratory Virus Seasons: New Strategies for Transmission Reduction and Population-Level Benefit - 6 month(s) ago
The Duke-Margolis Center for Health Policy, in collaboration with the Bill and Melinda Gates Foundation, will convene a public meeting focused on a new strategic direction for addressing the burden presented by respiratory viruses.
Source: healthpolicy.duke.eduCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 17Going the Distance: A Current View of Enhancer Action - 6 month(s) ago
In eukaryotes, transcription of genes by RNA polymerase II yields messenger RNA intermediates from which protein products are synthesized. Transcriptional enhancers are discrete DNA elements that contain specific sequence motifs with which DNA-binding …
Source: www.science.orgCategories: General Medicine News, Infectious DiseaseTweet
RT @FilippaLentzos: Nice piece from @HarvardChanSPH featuring @mlipsitch on @BulletinAtomic #PathogensProject https://t.co/OFrcinnadO